Finding out more about the origins of amyloid, the protein that forms plaques in the brains of Alzheimer's sufferers
One of the key biological hallmarks of Alzheimer’s disease is the presence of clumps of amyloid molecules in the brain, known as plaques. For many years, researchers have focused on figuring out why amyloid plaques form and how to get rid of them, yet these efforts haven’t led to effective treatments for what is currently an incurable condition. One issue is that amyloid is not only made in the brain but elsewhere in the body too, so it has been hard to figure out where it’s coming from. Researchers have recently managed to disentangle the two sources by using genetically engineered mice that make mouse amyloid in the brain and human amyloid in the liver. The human liver amyloid could still get into the brain (highlighted in red in these brains scans), triggering changes typically seen in Alzheimer’s disease and challenging our understanding of how the disease starts and progresses.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.